Registration of interest for RFP on tailored trachoma endgame strategies

Please complete the below form to register your interest in participating in the RFP for Operational research on tailored endgame strategies for persistent and recrudescent active trachoma. If you have any questions about filling out this form or would like to request a form in French or Portuguese language, please contact Katie Gass (kgass@taskforce.org).

Country name

Name(s) of primary point(s) of contact

Email address(es) of primary point(s) of contact

Title(s) and institution(s) of primary point(s) of contact

Any other institution(s) associated with the proposal

List the name(s) of the districts(s) with persistent/recrudescent trachoma that are part of this application for operational research funding

(Optional) When are you aiming to start the OR? Are there any anticipated time constraints for starting/conducting/finishing the OR?

Has a program review, desk review, or any other exercise been undertaken to determine the factors that may have contributed to persistence/recrudescence in any or all of the applying districts?

Denote whether each of the following conditions exist in one or more of the applying districts

Program delivery challenges

Missed rounds of MDA

Low MDA coverage

MDA refusal

Nomadic populations

Cross-border issues

Insecurity

Refugees/internally displaced persons

Diagnosis/interpretation

Additional diagnostic indicators are needed to confirm whether transmission is ongoing

Persistent/recrudescent TF may represent a statistical error

Concerns about TF grading

The sampled population (in TIS/TSS) does not appropriately represent the population targeted by MDA

Biological factors

Low/poor WASH coverage

High baseline prevalence/transmission pressure

Other condition(s) not previously listed

(Optional) Please add any additional information you feel is relevant, including any operational research questions and/or methods you think are most relevant for the applying districts

Send me a copy of my responses

Report Abuse